As the coronavirus outbreak escalated into a global pandemic, what was a problem for China investors quickly spread into other geographies. Fundraising, investment and exits inevitably took a hit
1) Investment: A staggered slowdown Four months ago, BGH Capital and Ontario Teachers’ Pension Plan (OTPP) were devising strategies to help New Zealand dental clinic operator Abano Healthcare develop...
Rob Kaplan is CEO of Singapore’s Circulate Capital, which is dedicated to reducing oceanic plastic pollution. Its $150 million debut fund is backed by the likes of Coca-Cola, PepsiCo, and Unilever
Australia’s Blackbird Ventures has raised A$500 million ($357 million) for its fourth fund and named Atlassian co-founder Mike Cannon-Brookes as chairman.
Yaoyanshe, a Chinese contract research organization (CRO) for novel drugs, has raised RMB600 million ($86 million) across two rounds in the past eight months.
MyGlamm, an online Indian cosmetics brand, has agreed to acquire POPxo, a women-focused content platform, for an undisclosed sum. Both companies have several VC backers.